Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000812118 | SCV000952422 | uncertain significance | Early infantile epileptic encephalopathy with suppression bursts | 2018-12-17 | criteria provided, single submitter | clinical testing | This sequence change replaces serine with asparagine at codon 1134 of the SCN1A protein (p.Ser1134Asn). The serine residue is highly conserved and there is a small physicochemical difference between serine and asparagine. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with SCN1A-related disease. This variant is present in population databases (rs753444206, ExAC 0.006%). |